| Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up N Gukasyan, AK Davis, FS Barrett, MP Cosimano, ND Sepeda, ... Journal of Psychopharmacology 36 (2), 151-158, 2022 | 252 | 2022 |
| Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... Jama 330 (9), 843-853, 2023 | 105 | 2023 |
| Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy N Gukasyan, SM Nayak Transcultural psychiatry 59 (5), 652-664, 2022 | 88 | 2022 |
| Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD AK Davis, FS Barrett, S So, N Gukasyan, TC Swift, RR Griffiths Journal of Psychopharmacology 35 (4), 437-446, 2021 | 83 | 2021 |
| Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports SM Nayak, N Gukasyan, FS Barrett, E Erowid, F Erowid, RR Griffiths Pharmacopsychiatry 54 (05), 240-245, 2021 | 46 | 2021 |
| Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation TS Kato, GR Stevens, J Jiang, PC Schulze, N Gukasyan, M Lippel, ... The Journal of Heart and Lung Transplantation 32 (3), 333-340, 2013 | 44 | 2013 |
| Psychedelics and consciousness: Distinctions, demarcations, and opportunities DB Yaden, MW Johnson, RR Griffiths, MK Doss, A Garcia-Romeu, ... International Journal of Neuropsychopharmacology 24 (8), 615-623, 2021 | 35 | 2021 |
| Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012–2017 N Gukasyan, EC Strain Drug and alcohol dependence 208, 107867, 2020 | 35 | 2020 |
| Hyperbaric oxygen therapy for the treatment of anastomotic complications after tracheal resection and reconstruction C Stock, N Gukasyan, A Muniappan, C Wright, D Mathisen The Journal of thoracic and cardiovascular surgery 147 (3), 1030-1035, 2014 | 32 | 2014 |
| The potential of psychedelics for end of life and palliative care DB Yaden, SM Nayak, N Gukasyan, BT Anderson, RR Griffiths Disruptive psychopharmacology, 169-184, 2021 | 17 | 2021 |
| Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms A Nikolaidis, R Lancelotta, N Gukasyan, RR Griffiths, FS Barrett, AK Davis Journal of affective disorders 324, 239-249, 2023 | 15 | 2023 |
| Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use N Gukasyan, RR Griffiths, DB Yaden, DG Antoine, SM Nayak Journal of Psychopharmacology 37 (7), 707-716, 2023 | 14 | 2023 |
| Psychedelic-assisted therapy for people with eating disorders N Gukasyan, CC Schreyer, RR Griffiths, AS Guarda Current psychiatry reports 24 (12), 767-775, 2022 | 14 | 2022 |
| Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use. ML Stitzer, N Gukasyan, T Matheson, JL Sorensen, DJ Feaster, R Duan, ... Psychology of Addictive Behaviors 34 (1), 23, 2020 | 13 | 2020 |
| Toward risk-benefit assessments in psychedelic-and MDMA-assisted therapies MM Bradberry, N Gukasyan, CL Raison JAMA psychiatry 79 (6), 525-527, 2022 | 12 | 2022 |
| Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol L Critchley, A Carrico, N Gukasyan, P Jacobs, RN Mandler, AE Rodriguez, ... Addiction science & clinical practice 15, 1-8, 2020 | 10 | 2020 |
| On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression N Gukasyan Med 4 (1), 8-9, 2023 | 9 | 2023 |
| The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial … AW Levin, R Lancelotta, ND Sepeda, N Gukasyan, S Nayak, TL Wagener, ... PloS one 19 (3), e0300501, 2024 | 6 | 2024 |
| Misinterpretations and omissions: a critical response to Goodwin and colleagues’ commentary on psilocybin-assisted therapy KC O’Donnell, BT Anderson, FS Barrett, MP Bogenschutz, CS Grob, ... American Journal of Psychiatry 181 (1), 74-75, 2024 | 5 | 2024 |
| What Is in a Name? The Many Meanings of “Psychedelic” KC O'Donnell, DE Roberts, THW Ching, G Glick, N Goldway, N Gukasyan, ... Psychedelic Medicine 1 (4), 187-189, 2023 | 4 | 2023 |
